Nonsedating α-2 agonists
US7141597B2 · kind B2 · utility
46Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2004 |
| Grant date | Nov 28, 2006 |
| Priority date | — |
| Expiry date | Jan 24, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D233/84
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an α-2A/α-1A selective agonist that includes a compound represented by Structure 1 or a pharmaceutically acceptable salt, ester, amide, sterioisomer or racemic mixture thereof. The present invention further provides a pharmaceutical composition that contains a pharmaceutical carrier and a therapeutically effective amount of an α-2A/α-1A selective agonist that includes a compound represented by Structure 1 or a pharmaceutically acceptable salt, ester, amide, sterioisomer or racemic mixture thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.